A Quick Primer GLP-1s (glucagon-like peptide-1 agonists) are injectable (or soon-to-be oral) drugs originally for type 2 diabetes
BPC157 and Neurotransmitter System Modulation: Brain-Gut Axis Research Research into the central nervous system implications of BPC157 has characterized potential interactions with dopaminergic, serotonergic, GABAergic, and opioid neurotransmitter systems across preclinical behavioral and neurobiological research paradigms relevant to murine models
At $129/mo flat available in all 50 states, five of which require a scheduled live consult instead of async intake Microdose comes in below Wegovy tablets' starter price ($149/mo), Tuyo Health ($155/mo), Breeze Meds ($199/mo), MEDVi's ongoing rate ($299/mo), and dramatically below Zepbound vials at any tier
Impact of GLP-1 Drug Adoption on Consumer Food Demand GLP-1 weight loss drugs are likely to impact long-term category growth rates for food consumption
By wrapping the glutathione molecule in this protective lipid shell, we allow it to bypass the harsh environment of the stomach